Cruz-Vera Marta, Lucena Rafael, Cárdenas Soledad, Valcárcel Miguel
Department of Analytical Chemistry, Marie Curie Building (Annex), Campus de Rabanales, University of Cordoba, E-14071 Córdoba, Spain.
J Chromatogr A. 2008 Aug 15;1202(1):1-7. doi: 10.1016/j.chroma.2008.06.035. Epub 2008 Jul 3.
Dynamic liquid-phase microextraction (dLPME) using an ionic liquid as acceptor phase is proposed for the determination of six non-steroidal anti-inflammatory drugs (NSAIDs) in human urine samples for the first time. The extraction is carried out in a simple and automatic flow configuration. The chemical affinity between the extractant (1-butyl-3-methylimidazolium hexafluorophosphate) and the analytes permits a selective isolation of the drugs from the sample matrix allowing also their preconcentration. The whole analytical method has been optimized taking into account all the chemical, physical and hydrodynamic variables. The proposed method is a valuable alternative for the analysis of these drugs in urine within the concentration range 0.1-10 microg mL(-1), allowing their determination at therapeutic and toxic levels. Limits of detection were in the range from 38 ng mL(-1) (indomethacin) to 70 ng mL(-1) (naproxen). The repeatability of the proposed method expressed as RSD (n=5) varied between 2.1% (flurbiprofen) and 3.8% (tolmetin).
首次提出以离子液体作为接受相的动态液相微萃取(dLPME)法用于测定人尿液样本中的六种非甾体抗炎药(NSAIDs)。萃取过程采用简单的自动流动配置。萃取剂(1-丁基-3-甲基咪唑六氟磷酸盐)与分析物之间的化学亲和力使得能够从样品基质中选择性分离药物,同时也实现了它们的预富集。考虑到所有化学、物理和流体动力学变量,对整个分析方法进行了优化。所提出的方法是分析尿液中浓度范围为0.1 - 10 μg mL⁻¹的这些药物的一种有价值的替代方法,能够在治疗和中毒水平下对其进行测定。检测限在38 ng mL⁻¹(吲哚美辛)至70 ng mL⁻¹(萘普生)范围内。所提出方法以相对标准偏差(RSD,n = 5)表示的重复性在2.1%(氟比洛芬)至3.8%(托美丁)之间变化。